Sachin Deshmukh
Overview
Explore the profile of Sachin Deshmukh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deshmukh S, Chand A, Ghorpade R
Biomed Phys Eng Express
. 2024 Oct;
10(6).
PMID: 39353464
A scaffold is a three-dimensional porous structure that is used as a template to provide structural support for cell adhesion and the formation of new cells. Metallic cellular scaffolds are...
2.
Bennett C, Rivers E, Woo W, Bloch M, Cheung K, Griffin P, et al.
J Infect Dis
. 2024 Jul;
230(1):e4-e16.
PMID: 39052718
Background: Mutations present in emerging SARS-CoV-2 variants permit evasion of neutralization with prototype vaccines. A novel Omicron BA.1 subvariant-specific vaccine (NVX-CoV2515) was tested alone or as a bivalent preparation with...
3.
Becker S, Deshmukh S, De Looze F, Francardo V, Lee J, McGirr A, et al.
Allergy
. 2024 Apr;
79(7):1858-1867.
PMID: 38581259
Rationale: Saline nasal sprays are frequently used in the management of seasonal allergic rhinitis (SAR) for the cleansing and clearing of aeroallergens from the nasal cavity. Also using a drug-free...
4.
Bennett C, Woo W, Bloch M, Cheung K, Griffin P, Mohan R, et al.
Lancet Infect Dis
. 2024 Mar;
24(6):581-593.
PMID: 38460525
Background: SARS-CoV-2 variants evade immunity despite vaccination with prototype COVID-19 vaccines or previous infection. The 2019nCoV-311 (part 2) study is evaluating immune responses after two booster doses of a vaccine...
5.
de Bruyn G, Wang J, Purvis A, Ruiz M, Adhikarla H, Alvi S, et al.
EClinicalMedicine
. 2023 Aug;
62:102109.
PMID: 37533419
Background: In a parallel-group, international, phase 3 study (ClinicalTrials.govNCT04762680), we evaluated prototype (D614) and Beta (B.1.351) variant recombinant spike protein booster vaccines with AS03-adjuvant (CoV2 preS dTM-AS03). Methods: Adults, previously...
6.
Kinariwala S, Deshmukh S
Multimed Tools Appl
. 2023 Feb;
:1-23.
PMID: 36747894
Nowadays, people use short text to portray their opinions on platforms of social media such as Twitter, Facebook, and YouTube, as well as on e-commerce websites such as Amazon and...
7.
Stengel S, Steube A, Kose-Vogel N, Kirchberger-Tolstik T, Deshmukh S, Bruns T
Gut
. 2020 Jun;
70(3):622-623.
PMID: 32571975
No abstract available.
8.
Frankel A, Deshmukh S, Reddy A, Lightcap J, Hayes M, McClellan S, et al.
Integr Cancer Ther
. 2019 Apr;
18:1534735419846379.
PMID: 31014119
The past decade has seen tremendous advances in both our understanding of cancer immunosuppressive microenvironments and colonic bacteria facilitated by immune checkpoint inhibitor antibodies and next generation sequencing, respectively. Because...
9.
Kaushik H, Deshmukh S, Mathur D, Tiwari A, Garg L
Bioinformation
. 2013 Aug;
9(12):617-21.
PMID: 23904738
Unlabelled: Epsilon toxin secreted by Clostridium perfringens types B and D has been directly implicated as the causative agent of fatal enterotoxemia in domestic animals. The aim of the present...
10.
Chhabra G, Sharma P, Anant A, Deshmukh S, Kaushik H, Gopal K, et al.
Bioinformation
. 2010 Oct;
4(7):278-89.
PMID: 20978600
In the present study, comparative genome analysis between Clostridium perfringens and the human genome was carried out to identify genes that are essential for the pathogen's survival, and non-homologous to...